Bionas and PRIMACYT to Develop Cell-Based Assay to Study Hepatotoxicity | GenomeWeb
NEW YORK (GenomeWeb News) - Bionas and PRIMACYT said today that they will jointly develop a cell-based assay using human liver cells to predict hepatotoxic effects of drugs and chemicals.
 
PRIMACYT, based in Schwerin, Germany, will supply the hepatocytes. The hepatocytes will be cultivated on Bionas metabolic chips with chemically defined media from PRIMACYT.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.